Skip to main content
. Author manuscript; available in PMC: 2010 Jul 28.
Published in final edited form as: Vaccine. 2008 Sep 19;26(48):6083–6091. doi: 10.1016/j.vaccine.2008.09.010

Figure 5.

Figure 5

TNA antibody titers elicited by S. Typhi Ty21a-PA prime followed by AVA boost. Mice were primed on days 0, 28 and 56 with Ty21a(pSECPA) (A) or Ty21a(pVDL9.3PA83ec) (B) and boosted on day 112 with Ty21a(pSECPA) (A), Ty21a(pVDL9.3PA83ec) (B) or AVA (A-B) as described in Figure 4. A control group was primed and boosted with AVA on days 0 and 112 (C). Data represent GMT and the 95% confidence intervals for each group. Arrows indicate each immunization. * indicates differences between groups primed with Ty21a-PA vs. Ty21a carrying empty plasmids (p<0.001). Inserts depict enlarged TNA titers between days 100 and 140 (the time points closer to the boost).